Ofatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders (Q94863286)
Jump to navigation
Jump to search
scientific article published in April 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Ofatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders |
scientific article published in April 2009 |
Statements
Ofatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders (English)
Cannon Milani
Daniel Mendez-Allwood